Comprehensive Biomarker Analysis of Responders and Non-Responders in a Phase IIa Trial of a CMV Vaccine Immunotherapeutic Candidate (VBI-1901) November 22, 2022 | Comprehensive Biomarker Analysis of Responders and Non-Responders in a Phase IIa Trial of a CMV Vaccine Immunotherapeutic Candidate (VBI-1901) Conference: 2022 Society for Neuro-Oncology (SNO) Annual Meeting Date: November 18, 2022